FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1996

Shipping list no.: 96-0240-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Food safety : oversight of the FDA Center for Veterinary Medicine : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, May 10, 1996.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.

January 1997

Shipping list no.: 97-0002-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA Modernization Act : implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2000-0166-P.Distributed to some depository libraries in microfiche.Microfiche.Mod...

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-23."Shipping list no.: 95-0306-P.Distributed to some depository libraries in microfi...

Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993.

United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Investigations and Oversight.

"No. 69."Shipping list no.: 94-0020-P.Distributed to some depository libraries in microfiche.Mode of...

FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Aging.

January 1995

Shipping list no.: 96-0004-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

Shipping list no.: 96-0129-P.Distributed to some depository libraries in microfiche.Cover title.Incl...

The need for FDA regulatory reform to protect the health and safety of Americans : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 9, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1996

Shipping list no.: 97-0097-P.Distributed to some depository libraries in microfiche.Mode of access: ...

Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

January 1993

Shipping list no.: 93-0181-P.Distributed to some depository libraries in microfiche.Includes bibliog...

FDA reform legislation : hearings before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on H.R. 3199, 3200, and 3201, May 1 and 2, 1996.

United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment.

January 1996

"Serial no. 104-99."Shipping list no.: 97-0009-P.Distributed to some depository libraries in microfi...

A consumer's perspective on medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, March 30, 1995.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-18."Shipping list no.: 95-0229-P.Distributed to some depository libraries in microfi...

FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-129."Shipping list no.: 92-0515-P.Distributed to some depository libraries in microf...

Food and Drug enforcement standards for medical devices : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, September 14, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations .
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0152-P.Distributed to some depository libraries in microfiche.Includes bibliog...

The FDA and the future of American biomedical and food industries : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session, on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, biotech, medical device, and food industries, and FDA's regulation of these industries, April 5 and 6, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1995

Shipping list no.: 95-0243-P.Distributed to some depository libraries in microfiche.Includes bibliog...

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-132."Shipping list no.: 92-0573-P.Distributed to some depository libraries in microf...

Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1996

Shipping list no.: 96-0240-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Food safety : oversight of the FDA Center for Veterinary Medicine : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, May 10, 1996.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.

January 1997

Shipping list no.: 97-0002-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA Modernization Act : implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2000-0166-P.Distributed to some depository libraries in microfiche.Microfiche.Mod...

Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-23."Shipping list no.: 95-0306-P.Distributed to some depository libraries in microfi...

Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993.

United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Investigations and Oversight.

"No. 69."Shipping list no.: 94-0020-P.Distributed to some depository libraries in microfiche.Mode of...

FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Aging.

January 1995

Shipping list no.: 96-0004-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

Shipping list no.: 96-0129-P.Distributed to some depository libraries in microfiche.Cover title.Incl...

The need for FDA regulatory reform to protect the health and safety of Americans : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 9, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1996

Shipping list no.: 97-0097-P.Distributed to some depository libraries in microfiche.Mode of access: ...

Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

January 1993

Shipping list no.: 93-0181-P.Distributed to some depository libraries in microfiche.Includes bibliog...

FDA reform legislation : hearings before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on H.R. 3199, 3200, and 3201, May 1 and 2, 1996.

United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment.

January 1996

"Serial no. 104-99."Shipping list no.: 97-0009-P.Distributed to some depository libraries in microfi...

A consumer's perspective on medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, March 30, 1995.

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 104-18."Shipping list no.: 95-0229-P.Distributed to some depository libraries in microfi...

FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-129."Shipping list no.: 92-0515-P.Distributed to some depository libraries in microf...

Food and Drug enforcement standards for medical devices : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, September 14, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations .
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0152-P.Distributed to some depository libraries in microfiche.Includes bibliog...

The FDA and the future of American biomedical and food industries : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session, on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, biotech, medical device, and food industries, and FDA's regulation of these industries, April 5 and 6, 1995.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1995

Shipping list no.: 95-0243-P.Distributed to some depository libraries in microfiche.Includes bibliog...

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-132."Shipping list no.: 92-0573-P.Distributed to some depository libraries in microf...

Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996.

United States. Congress. Senate. Committee on Labor and Human Resources.

January 1996

Shipping list no.: 96-0240-P.Distributed to some depository libraries in microfiche.Includes bibliog...

Food safety : oversight of the FDA Center for Veterinary Medicine : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, May 10, 1996.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.

January 1997

Shipping list no.: 97-0002-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA Modernization Act : implementation of the law : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session on examining the Food and Drug Administration Modernization Act (P.L. 105-115), focusing on provisions on pharmaceuticals and medical devices, October 21, 1999.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2000

Shipping list no.: 2000-0166-P.Distributed to some depository libraries in microfiche.Microfiche.Mod...

FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

Abstract

Extracted data

FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

Abstract

Extracted data

Related items

Related items